Loratadine/Montelukast Sodium
氯雷他定/孟鲁司特钠
Report date: 2022/07/04 19:38:02
Base Information
Drug NameLoratadine/Montelukast Sodium
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes MontelukastLoratadine
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLCOrganon & Co
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A